期刊文献+

基于时间序列模型评估淀粉样蛋白引起的脑血管内皮功能损伤

Evaluating cerebral endothelial dysfunction induced by amyloid based on the time series model
下载PDF
导出
摘要 建立时间序列模型评估β-淀粉样蛋白(Aβ)引起的脑血管内皮功能损伤,探讨相关标记物对脑血管内皮功能损伤的影响和贡献程度。将永生化人脑微血管内皮细胞(HCMEC/D3)与2.5μmol/L Aβ共同孵育,在2,4,6,8,10,12,14,16,18,20,22,24 h分别测定胞浆Ca^(2+)、线粒体膜电位(MMP)、内皮型一氧化氮合酶(eNOS)活性和细胞活力,借助时间序列模型探讨相关标记物对细胞损伤的影响和贡献程度。脉冲响应分析表明,给胞浆Ca^(2+)一个正冲击后,细胞活力被抑制并持续走低;给eNOS和MMP一个正冲击后,细胞活力上升,并在早期上升速度较快,晚期上升速率有所下降。方差解析表明胞浆Ca^(2+)水平在脑血管内皮细胞损伤中占主要作用,且这种影响随着疾病进程的发展而下降。结合模型研究推断在损伤早期干预Ca^(2+)通道有可能改善Aβ引起的脑血管内皮功能损伤。 Time series model was developed to investigate the effect and contributions of related biomarkers on the cerebral endothelial dysfunction induced by beta amyloid(Aβ).HCMEC/D3 was incubated with 2.5μmol/L Aβfor 2,4,6,8,10,12,14,16,18,20,22 and 24 h,and biomarkers including cytosolic calcium ion,mitochondrial membrane potential(MMP),endothelial nitric oxide synthase(eNOS)and cell viability were determined.Time series model was established to assess the dynamic relationship between the related biomarkers and cell viability and the contribution of different biomarkers to cell damage.Impulse response analysis indicated that after a positive impact on cytosolic calcium ion,cell viability decreased and this impact continued to decline;after a positive impact on endothelial nitric oxide synthase and mitochondrial membrane potential,cell viability increases,which increased rapidly in the early stage,and the rate decreased in later stage.The result of variance decomposition showed that the cytosolic calcium ion played a major role in cerebral endothelial dysfunction induced by Aβ.Combined with the model study,it is concluded that the intervention on the level of cytosolic calcium ion at the early stage may be the possible way to slow the disease progression.
作者 朱成燕 刘昊晨 何华 柳晓泉 ZHU Chengyan;LIU Haochen;HE Hua;LIU Xiaoquan(Department of Pharmacokinetics,China Pharmaceutical University,Nanjing 210009,China)
出处 《中国药科大学学报》 CAS CSCD 北大核心 2018年第4期456-462,共7页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81473274 No.81773806 No.81503145)~~
关键词 时间序列模型 脑血管内皮功能损伤 淀粉样蛋白 钙离子通道 time series model cerebral endothelial dysfunction amyloid calcium ion channels
  • 相关文献

参考文献1

二级参考文献36

  • 1廖国超,聂爱华,肖军海,钟武,李松.β-分泌酶抑制剂的研究进展[J].中国药物化学杂志,2006,16(6):373-379. 被引量:9
  • 2金桂芳,梅寒芳,杨红.阿尔茨海默病的发病机制及药物治疗进展[J].广东药学院学报,2006,22(6):697-700. 被引量:14
  • 3Brookmeyer R, Johnson E,Ziegler-Graham K,et al. Forecasting the global burden of Alzheimer' s disease [ J ]. Alzheimers Dement,2007,3 ( 3 ) : 186 - 191.
  • 4Neugroschl J, Sano M. Current treatment and recent clinical research in Alzheimer's disease [J]. Mt Sinai J Med, 2010,77 (1):3 -16.
  • 5Giacobini E. Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer' disease [ J ]. J Neural Transm Suppl,2002, ( 62 ) : 181 - 187.
  • 6Nieoullon A. Acetylcholinesterase inhibitors in Alzheimer's disease : further comments on their mechanisms of action and therapeutic consequences [ J ]. Psychol Neuropsychiatr Vieil, 2010,8 (2) :123 -131.
  • 7Mangialasche F, Solomon A, Winblad B,et al. Alzheimer's disease : clinical trials and drug development [ J ]. Lancet Neurol, 2010,9(7) :702 -716.
  • 8Thomas SJ,Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias[ J]. Clin Interv Aging,2009,4:367 - 377.
  • 9Geldenhuys WJ,Van der Schyf CJ. The serotonin 5-HT6 receptor:a viable drug target for treating cognitive deficits in Alzheimer's disease[J]. Expert Rev Neurother,2009,9 (7) : 1 073 - 1 085.
  • 10Leurs R, Bakker RA, Timmennan H, et al. The histamine H3 receptor: from gene cloning to H3 receptor drugs [J]. Nat Rev Drug Discov, 2005,4(2) : 107 - 120.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部